Stock listing
NASDAQ:RAPT RAPT Therapeutics Inc Stock
Follow RAPT Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RAPT
$58.01 USD
Close on Mar 2, 2026 · No longer trades
- Lowest – highest close
- $7.33 – $58.01 USDSince Jun 16, 2025 · lowest Jul 1, 2025 · highest Mar 2, 2026
Delisted NASDAQ:RAPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RAPT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest deck · Jan 14, 2026
Investor Presentation (January 2026)
Investor deck · 28 slides
RAPT Therapeutics Inc on 6ix
- Decks
- 13 decks · latest Jan 14, 2026
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2026) | Investor deck | 28 slides | Jan 14, 2026 |
| Corporate Update (October 2025) | Corporate update | 18 slides | Oct 20, 2025 |
| Investor Presentation (July 2025) | Investor deck | 25 slides | Jul 8, 2025 |
| Investor Presentation (June 2025) | Investor deck | 25 slides | Jun 9, 2025 |
| Investor Presentation (January 2025) | Investor deck | 25 slides | Jan 13, 2025 |
| Investor Presentation (December 2024) | Investor deck | 21 slides | Dec 23, 2024 |
| Investor Presentation (March 2023) | Investor deck | 28 slides | Mar 14, 2023 |
| Investor Presentation (January 2023) | Investor deck | 28 slides | Jan 9, 2023 |
| Investor Presentation (September 2022) | Investor deck | 29 slides | Sep 6, 2022 |
| Investor Presentation (September 2021) | Investor deck | 26 slides | Sep 27, 2021 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2021) | Technical | 15 slides | Jun 14, 2021 |
| Technical Presentation (November 2020) | Technical | 29 slides | Nov 16, 2020 |
| Investor Presentation (January 2020) | Investor deck | 37 slides | Jan 9, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mary Ann Gray Other companies: BioAtla, Inc. (Director · Since at least Jun 16, 2022); Keros Therapeutics, Inc. (Director · Since at least Jun 1, 2022); Compass Therapeutics, Inc. (President, Gray Strategic Advisors, LLC · Since at least Apr 26, 2022); Palisade Bio, Inc. (Director · Jun 11, 2023 – Nov 21, 2023 · Past) | Director · Since at least Mar 31, 2022 |
| Peter Svennilson Other companies: Revolution Medicines, Inc. (Director · Jun 17, 2020 – Apr 26, 2021 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Gritstone bio, Inc. (Director · Jun 19, 2019 – Jun 19, 2019 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 8, 2020 · Past) | Director · Jun 18, 2020 – May 28, 2021 · Past |
| William Rieflin Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past) | Director · Oct 30, 2019 – May 22, 2024 · Past |
| Ashley L Dombkowski Other companies: Hudson Executive Investment Corp III (Director · Feb 23, 2021 – Feb 23, 2021 · Past) | Director · Since at least Jun 21, 2025 |
| Dirk G Brockstedt Other companies: Aduro Biotech Inc (EVP of Research and Dev. · Oct 2, 2017 – Dec 29, 2017 · Past) | CHIEF SCIENTIFIC OFFICER · Since at least Oct 30, 2019 |
| Michael F Giordano Other companies: Epizyme Inc (Director · Jun 11, 2021 – Aug 12, 2022 · Past) | Director · Since at least May 28, 2021 |
| Eric J Hall | Interim CFO · Oct 30, 2019 – Oct 30, 2019 · Past |
| Rodney KB Young | CHIEF FINANCIAL OFFICER · Since at least May 10, 2022 |
| Wendye Robbins | Director · Jun 29, 2020 – Mar 31, 2025 · Past |
| William Ho | CHIEF MEDICAL OFFICER · Since at least Oct 30, 2019 |
Log in to ask 6ix AI your own questions about RAPT Therapeutics Inc.